Intrathecal baclofen therapy can improve spasticity associated with infantile-onset dentatorubral-pallidoluysian atrophy: illustrative cases.
Tomoyoshi Nakagawa(The University of Osaka), Haruhiko Kishima(Osaka University Hospital), Shin Nabatame(Osaka University Hospital), Hui Ming Khoo(The University of Osaka), Satoru Oshino(The University of Osaka), Motohisa Hayashi(The University of Osaka), Koichi Hosomi(RELX Group (Netherlands)), Shuhei Kawabata(The University of Osaka), Rie Nakai(The University of Osaka), Naoki Tani(Osaka Gakuin University), Ryoko Kuwayma(The University of Osaka), Kuriko Kagitani‐Shimono(Osaka University Hospital)
Cited by 0
Related Papers
PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria
|Nature Communications|2012|599
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
|The Lancet|2014|436
MEIOSIN Directs the Switch from Mitosis to Meiosis in Mammalian Germ Cells
|Developmental Cell|2020|211